MedMen to Steer Away from Cannabis Growing and Production


As reported previously, the retail cannabis chain MedMen has been going through significant changes over the past year. Now, as reported by CNN Business and announced on today’s 2nd quarter stockholder conference call, MedMen is planning to focus its business 100% on retail, dropping cannabis cultivation and processing from its business model.

MedMen Quits Cultivation

MedMen’s interim CEO, Ryan Lissack, says that the company sees that the industry is steering away from vertical integration and moving toward a fragmented value chain with specialists within each vertical. So, grow and processing services will be outsourced going forward. With earnings increasing by 50% over last year but net loss exploding from $18.7 million to $40.6 million, MedMen also plans to examine each of their retail locations to ensure profitability at the store level.


Leave a reply

We gotta ask... Are you 21+? This website requires you to be 21 years of age or older. Please verify your age to view the content, or click "Exit" to leave.